Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study
Open Access
- 23 August 2024
- journal article
- research article
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 48, 100846
Abstract
No abstract availableKeywords
Funding Information
- Region Örebro län
This publication has 31 references indexed in Scilit:
- ESMO Guidance for Reporting Oncology real-World evidence (GROW)Annals of Oncology, 2023
- Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective AnalysisEuropean Urology, 2020
- Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node CoverageEuropean Urology, 2017
- Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data BaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Dose–Volume Relationships for Acute Bowel Toxicity in Patients Treated With Pelvic Nodal Irradiation for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994